位置:首页 > 蛋白库 > ECTD_VIRSA
ECTD_VIRSA
ID   ECTD_VIRSA              Reviewed;         300 AA.
AC   Q2TDY4;
DT   16-APR-2014, integrated into UniProtKB/Swiss-Prot.
DT   24-JAN-2006, sequence version 1.
DT   03-AUG-2022, entry version 48.
DE   RecName: Full=Ectoine dioxygenase {ECO:0000303|PubMed:17636255};
DE            EC=1.14.11.55 {ECO:0000269|PubMed:17636255, ECO:0000269|PubMed:24714029};
DE   AltName: Full=Ectoine hydroxylase {ECO:0000303|PubMed:17636255};
GN   Name=ectD {ECO:0000303|PubMed:17636255};
OS   Virgibacillus salexigens (Salibacillus salexigens).
OC   Bacteria; Firmicutes; Bacilli; Bacillales; Bacillaceae; Virgibacillus.
OX   NCBI_TaxID=61016;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], PROTEIN SEQUENCE OF 1-15, FUNCTION,
RP   CATALYTIC ACTIVITY, ACTIVITY REGULATION, BIOPHYSICOCHEMICAL PROPERTIES,
RP   INDUCTION, MASS SPECTROMETRY, AND COFACTOR.
RC   STRAIN=ATCC 700290 / DSM 11483 / CCUG 52350 / JCM 30552 / C-20Mo;
RX   PubMed=17636255; DOI=10.1074/jbc.m704023200;
RA   Bursy J., Pierik A.J., Pica N., Bremer E.;
RT   "Osmotically induced synthesis of the compatible solute hydroxyectoine is
RT   mediated by an evolutionarily conserved ectoine hydroxylase.";
RL   J. Biol. Chem. 282:31147-31155(2007).
RN   [2]
RP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) IN COMPLEX WITH IRON, AND COFACTOR.
RX   PubMed=20498719; DOI=10.1371/journal.pone.0010647;
RA   Reuter K., Pittelkow M., Bursy J., Heine A., Craan T., Bremer E.;
RT   "Synthesis of 5-hydroxyectoine from ectoine: crystal structure of the non-
RT   heme iron(II) and 2-oxoglutarate-dependent dioxygenase EctD.";
RL   PLoS ONE 5:E10647-E10647(2010).
RN   [3]
RP   X-RAY CRYSTALLOGRAPHY (1.78 ANGSTROMS), FUNCTION, CATALYTIC ACTIVITY,
RP   BIOPHYSICOCHEMICAL PROPERTIES, COFACTOR, AND SUBUNIT.
RX   PubMed=24714029; DOI=10.1371/journal.pone.0093809;
RA   Widderich N., Hoppner A., Pittelkow M., Heider J., Smits S.H., Bremer E.;
RT   "Biochemical properties of ectoine hydroxylases from extremophiles and
RT   their wider taxonomic distribution among microorganisms.";
RL   PLoS ONE 9:e93809-e93809(2014).
CC   -!- FUNCTION: Involved in the biosynthesis of 5-hydroxyectoine, called
CC       compatible solute, which helps organisms to survive extreme osmotic
CC       stress by acting as a highly soluble organic osmolyte. Catalyzes the 2-
CC       oxoglutarate-dependent selective hydroxylation of L-ectoine to yield
CC       (4S,5S)-5-hydroxyectoine. {ECO:0000269|PubMed:17636255,
CC       ECO:0000269|PubMed:24714029}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=2-oxoglutarate + L-ectoine + O2 = 5-hydroxyectoine + CO2 +
CC         succinate; Xref=Rhea:RHEA:45740, ChEBI:CHEBI:15379,
CC         ChEBI:CHEBI:16526, ChEBI:CHEBI:16810, ChEBI:CHEBI:30031,
CC         ChEBI:CHEBI:58515, ChEBI:CHEBI:85413; EC=1.14.11.55;
CC         Evidence={ECO:0000269|PubMed:17636255, ECO:0000269|PubMed:24714029};
CC   -!- COFACTOR:
CC       Name=Fe(2+); Xref=ChEBI:CHEBI:29033;
CC         Evidence={ECO:0000269|PubMed:17636255, ECO:0000269|PubMed:20498719,
CC         ECO:0000269|PubMed:24714029};
CC       Note=Binds 1 Fe(2+) ion. {ECO:0000269|PubMed:20498719,
CC       ECO:0000269|PubMed:24714029};
CC   -!- ACTIVITY REGULATION: Stimulated by FeSO(4) up to a concentration of 1
CC       mM, whereas higher concentrations inhibited the ectoine hydroxylase.
CC       Also inhibited by ascorbate. {ECO:0000269|PubMed:17636255}.
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=3.5 mM for ectoine (at pH 7.5 and 32 degrees Celsius)
CC         {ECO:0000269|PubMed:17636255};
CC         KM=4.9 mM for 2-oxoglutarate (at pH 7.5 and 32 degrees Celsius)
CC         {ECO:0000269|PubMed:24714029};
CC         KM=5.2 mM for 2-oxoglutarate (at pH 7.5 and 32 degrees Celsius)
CC         {ECO:0000269|PubMed:17636255};
CC         KM=5.9 mM for ectoine (at pH 7.5 and 32 degrees Celsius)
CC         {ECO:0000269|PubMed:24714029};
CC         Vmax=13.8 umol/min/mg enzyme (at pH 7.5 and 32 degrees Celsius)
CC         {ECO:0000269|PubMed:17636255};
CC         Vmax=6.4 umol/min/mg enzyme (at pH 7.5 and 32 degrees Celsius)
CC         {ECO:0000269|PubMed:24714029};
CC         Note=kcat is 7.7 sec(-1) for ectoin as substrate (at pH 7.5 and 32
CC         degrees Celsius). {ECO:0000269|PubMed:24714029};
CC       pH dependence:
CC         Optimum pH is 7.5. {ECO:0000269|PubMed:17636255,
CC         ECO:0000269|PubMed:24714029};
CC       Temperature dependence:
CC         Optimum temperature is 32 degrees Celsius (PubMed:17636255,
CC         PubMed:24714029). Active from 5 to 50 degrees Celsius
CC         (PubMed:24714029). {ECO:0000269|PubMed:17636255,
CC         ECO:0000269|PubMed:24714029};
CC   -!- SUBUNIT: Homodimer. {ECO:0000269|PubMed:24714029}.
CC   -!- INDUCTION: Induced under high salinity stress and stationary growth
CC       phase. Increased ectoine biosynthesis occurs as soon as the cells start
CC       to grow in high osmolality medium, but there is no immediate 5-
CC       hydroxyectoine production. Appreciable amounts of 5-hydroxyectoine are
CC       made only when cell growth slowed and the culture enters in stationary
CC       growth phase. {ECO:0000269|PubMed:17636255}.
CC   -!- MASS SPECTROMETRY: Mass=34400; Method=Unknown;
CC       Evidence={ECO:0000269|PubMed:17636255};
CC   -!- SIMILARITY: Belongs to the PhyH family. EctD subfamily. {ECO:0000305}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AY935522; AAY29689.1; -; Genomic_DNA.
DR   PDB; 3EMR; X-ray; 1.85 A; A=1-300.
DR   PDB; 4NMI; X-ray; 1.78 A; A=1-300.
DR   PDBsum; 3EMR; -.
DR   PDBsum; 4NMI; -.
DR   AlphaFoldDB; Q2TDY4; -.
DR   SMR; Q2TDY4; -.
DR   KEGG; ag:AAY29689; -.
DR   BRENDA; 1.14.11.55; 8050.
DR   EvolutionaryTrace; Q2TDY4; -.
DR   GO; GO:0016706; F:2-oxoglutarate-dependent dioxygenase activity; IDA:UniProtKB.
DR   GO; GO:0005506; F:iron ion binding; IDA:UniProtKB.
DR   GO; GO:0042400; P:ectoine catabolic process; IDA:UniProtKB.
DR   InterPro; IPR012774; EctD.
DR   InterPro; IPR008775; Phytyl_CoA_dOase.
DR   Pfam; PF05721; PhyH; 1.
DR   TIGRFAMs; TIGR02408; ectoine_ThpD; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Dioxygenase; Direct protein sequencing; Iron; Metal-binding;
KW   Oxidoreductase.
FT   CHAIN           1..300
FT                   /note="Ectoine dioxygenase"
FT                   /id="PRO_0000428756"
FT   REGION          1..23
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         129
FT                   /ligand="L-ectoine"
FT                   /ligand_id="ChEBI:CHEBI:58515"
FT                   /evidence="ECO:0000250|UniProtKB:Q1GNW5"
FT   BINDING         135
FT                   /ligand="2-oxoglutarate"
FT                   /ligand_id="ChEBI:CHEBI:16810"
FT                   /evidence="ECO:0000250|UniProtKB:Q1GNW5"
FT   BINDING         146
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000269|PubMed:20498719,
FT                   ECO:0007744|PDB:3EMR"
FT   BINDING         148
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000269|PubMed:20498719,
FT                   ECO:0007744|PDB:3EMR"
FT   BINDING         248
FT                   /ligand="Fe cation"
FT                   /ligand_id="ChEBI:CHEBI:24875"
FT                   /evidence="ECO:0000269|PubMed:20498719,
FT                   ECO:0007744|PDB:3EMR"
FT   SITE            152
FT                   /note="Important for ectoine stabilization"
FT                   /evidence="ECO:0000250|UniProtKB:Q1GNW5"
FT   STRAND          8..11
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          14..17
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   HELIX           27..32
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          33..35
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   HELIX           37..46
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          47..51
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   HELIX           57..73
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   TURN            74..76
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          82..84
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   TURN            86..88
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          91..95
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   HELIX           97..100
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   HELIX           102..108
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   HELIX           111..121
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          125..133
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          143..146
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   HELIX           148..156
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          163..171
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          175..177
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   HELIX           186..188
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          189..192
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   HELIX           216..226
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          239..243
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          248..250
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   STRAND          261..268
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   HELIX           269..271
FT                   /evidence="ECO:0007829|PDB:4NMI"
FT   TURN            285..287
FT                   /evidence="ECO:0007829|PDB:4NMI"
SQ   SEQUENCE   300 AA;  34406 MW;  0913B16BBCB96BE2 CRC64;
     MEDLYPSRQN NQPKILKRKD PVIYTDRSKD NQAPITKEQL DSYEKNGFLQ IKNFFSEDEV
     IDMQKAIFEL QDSIKDVASD KVIREPESND IRSIFHVHQD DNYFQDVAND KRILDIVRHL
     LGSDVYVHQS RINYKPGFKG KEFDWHSDFE TWHVEDGMPR MRAISVSIAL SDNYSFNGPL
     MLIPGSHNYF VSCVGETPDN NYKESLKKQK LGVPDEESLR ELTRIGGGIS VPTGKAGSVT
     LFESNTMHGS TSNITPYPRN NLFMVYNSVK NRLVEPFSGG EKRPEYIAVR EKQPVYSAVN
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024